Crossmark

Does the last 20 years paradigm of clinical research using volatile organic compounds to non-invasively diagnose cancer need to change? Challenges and future direction

Crossref DOI link: https://doi.org/10.1007/s00432-023-04940-7

Published Online: 2023-06-05

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tan, Shi-Yan

Ma, Qiong

Li, Fang

Jiang, Hua

Peng, Xiao-Yun

Dong, Jing

Ye, Xin

Wang, Qiao-Ling

You, Feng-Ming

Fu, Xi

Ren, Yi-Feng
Funding

Funding for this research was provided by:

Qiao-Ling Wang (2022NSFSC0670)

Feng-Ming You (2022ZDZX0022)
License Information

Text and Data Mining valid from 2023-06-05

Version of Record valid from 2023-06-05
More Information

Article History

Received: 2 May 2023

Accepted: 24 May 2023

First Online: 5 June 2023

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below